Serono Nears Settlement In Serostim Investigation, Sets Aside $725 Mil.
Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)
Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)